J&J Remediates Two OTC Facilities To FDA Approval, Waits On Third
This article was originally published in The Tan Sheet
Its headquarters plant was closed and production at two other facilities was slowed under a 2011 consent decree. J&J did not say when it expects FDA’s decision on the third plant.
Register for our free email digests: